CLINICAL_TRIALS
trial_result
· 2020-05-12
Clinical Trial Update: Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma [Phase 3]
Summary
Phase 3 trial comparing TRC105 plus pazopanib versus pazopanib alone in advanced angiosarcoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tracon Pharmaceuticals Inc. | Conditions: Advanced Angiosarcoma | Phase 3 | Status: COMPLETED | Results posted: 2020-05-12